CRLComplete Response Letter
Complete Response Letter King Pharmaceuticals, Inc. (May 15, 2009)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• ALSUMA
